Silexion Therapeutics Ltd.
SLXN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,519 | -$5,108 | -$3,488 | -$755 |
| Dep. & Amort. | $25 | $45 | $57 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,862 | $130 | $125 | $0 |
| Change in WC | -$1,580 | $87 | $239 | -$470 |
| Other Non-Cash | $3,816 | $317 | -$268 | -$182 |
| Operating Cash Flow | -$8,396 | -$4,529 | -$3,335 | -$1,407 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | -$12 | -$40 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$500 | $0 |
| Inv. Sales/Matur. | $0 | $507 | $16 | $0 |
| Other Inv. Act. | $0 | $78 | $0 | $0 |
| Investing Cash Flow | -$22 | $573 | -$524 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$250 | $0 | $0 | $150 |
| Stock Issued | $3,054 | $0 | $0 | $118,800 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,300 | $522 | $2,752 | -$2,549 |
| Financing Cash Flow | $5,104 | $522 | $2,752 | $116,401 |
| Forex Effect | -$61 | -$230 | -$667 | -$115,006 |
| Net Chg. in Cash | -$3,375 | -$3,664 | -$1,774 | -$13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,645 | $8,309 | $10,083 | $52 |
| End Cash | $1,270 | $4,645 | $8,309 | $39 |
| Free Cash Flow | -$8,418 | -$4,541 | -$3,375 | -$1,407 |